Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed

ByAmber Hill, PhD,Andy Studna, Senior Editor

August 21st 2026

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment

ByAndy Studna, Senior Editor

August 21st 2026

© tippapatt - © tippapatt - stock.adobe.com

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

ByAndy Studna, Senior Editor

August 20th 2026

Where AI Has the Most Immediate Impact in Phase I Execution

ByAmber Hill, PhD,Andy Studna, Senior Editor

August 20th 2026

ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA Commissioner

ByAndy Studna, Senior Editor

August 20th 2026

From the Publisher

Articles in this issue

Related Content

What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

Where AI Has the Most Immediate Impact in Phase I Execution

ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA Commissioner

Trending on Applied Clinical Trials Online

One Clinical: Working Together to Advance Trial Collaboration

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical Devices

ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA Commissioner

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships